2001
DOI: 10.1258/0023677011911345
|View full text |Cite
|
Sign up to set email alerts
|

Refining procedures for the administration of substances

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
59
0
9

Year Published

2012
2012
2024
2024

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 190 publications
(69 citation statements)
references
References 25 publications
1
59
0
9
Order By: Relevance
“…However, the current availability of formulations of etomidate is very limited and, to the best of our knowledge, etomidate is only available in a concentration of 2 mg/mL. This means that injection volumes needed for at least one hour of sedation exceed the animal welfare guidelines . A recent paper showed that it was possible to measure unilateral BOLD responses upon a somatosensory stimulus repeatedly in the same mouse anesthesized with a novel ketamine/xylazine formulation .…”
Section: Discussionmentioning
confidence: 99%
“…However, the current availability of formulations of etomidate is very limited and, to the best of our knowledge, etomidate is only available in a concentration of 2 mg/mL. This means that injection volumes needed for at least one hour of sedation exceed the animal welfare guidelines . A recent paper showed that it was possible to measure unilateral BOLD responses upon a somatosensory stimulus repeatedly in the same mouse anesthesized with a novel ketamine/xylazine formulation .…”
Section: Discussionmentioning
confidence: 99%
“…The doses suggested in OECD TG 420 for investigating the toxicity of test chemicals are from 5 to 5000 mg/kg. We chose the concentration of 5 mg/Kg based on the maximum volume possible to administer to the animal by intraperitoneal pathway (10 mL/Kg) [ 23 ] and the maximum capacity of encapsulation of the chalcones into the nanoemulsion (0.5 mg/mL). A single dose was chosen to minimize the use of animals.…”
Section: Methodsmentioning
confidence: 99%
“…This fact could be explained by that fact that in the intraperitoneal route, absorption occurs through the mesenteric vessels, draining to the portal vein, and thereby accessing the bloodstream in less time than by the oral route (Turner et al, 2011), making this a more rapid absorption route (Morton et al, 2001). Regarding the values obtained of k e , t 1/2 and the Cl/f, no significant difference was found that could be attributed to the administration route.…”
Section: Pharmacokineticmentioning
confidence: 97%